1.A patient with homocystinuria complicated by superior sagittal sinus thrombosis: A case report.
Jaseong KOO ; Byung Woo YOON ; Sunghun KIM
Journal of the Korean Neurological Association 1997;15(6):1271-1279
Homocystinuria is an inborn error of methionine metabolism and has several causes. Among the causes, cystathionine-b-synthase deficiency is the most common. The major clinical manifestations are ectopia lectis skeletal deformities, mental retardation and occlusive vascular disease A 16 year old girl was admitted with generalized seizure. She had a history of bilateral lens dislocation and thoracic scoliosis. Her brain MRI and MRA showed mass-like lesions at both frontal area and diffuses, stenosis of the right internal carotid artery She underwent a stereotaxic brain biopsy and cerebral angiography. Two days, after angiography, she was suddenly aggravated to show stuporous mentality and quadriplegia. FoIlow-up brain MRI showed newly developed acute ischemic lesions at both parietal area MR venography confirmed superior sagittal sinus thrombosis. Methionine and homocystine were markedly elevated in plasma and 24 hour urine. She recovered with anticoagulation and vitamin supplementation(folate and pyridoxine). Homocystinuria should be suspected in stroke patients of young age, especially if thy have nontraumatic lens dislocation or marfanoid features. We report a patient with homocystinuria complicated by cerebral venous sinus thrombosis which was aggrevated after cerebral angiography.
Adolescent
;
Angiography
;
Biopsy
;
Brain
;
Carotid Artery, Internal
;
Cerebral Angiography
;
Congenital Abnormalities
;
Constriction, Pathologic
;
Female
;
Homocystine
;
Homocystinuria*
;
Humans
;
Intellectual Disability
;
Lens Subluxation
;
Magnetic Resonance Imaging
;
Metabolism
;
Methionine
;
Phlebography
;
Plasma
;
Quadriplegia
;
Rabeprazole
;
Scoliosis
;
Seizures
;
Sinus Thrombosis, Intracranial
;
Stroke
;
Stupor
;
Superior Sagittal Sinus*
;
Thrombosis*
;
Vascular Diseases
;
Vitamins
2.A patient with homocystinuria complicated by superior sagittal sinus thrombosis: A case report.
Jaseong KOO ; Byung Woo YOON ; Sunghun KIM
Journal of the Korean Neurological Association 1997;15(6):1271-1279
Homocystinuria is an inborn error of methionine metabolism and has several causes. Among the causes, cystathionine-b-synthase deficiency is the most common. The major clinical manifestations are ectopia lectis skeletal deformities, mental retardation and occlusive vascular disease A 16 year old girl was admitted with generalized seizure. She had a history of bilateral lens dislocation and thoracic scoliosis. Her brain MRI and MRA showed mass-like lesions at both frontal area and diffuses, stenosis of the right internal carotid artery She underwent a stereotaxic brain biopsy and cerebral angiography. Two days, after angiography, she was suddenly aggravated to show stuporous mentality and quadriplegia. FoIlow-up brain MRI showed newly developed acute ischemic lesions at both parietal area MR venography confirmed superior sagittal sinus thrombosis. Methionine and homocystine were markedly elevated in plasma and 24 hour urine. She recovered with anticoagulation and vitamin supplementation(folate and pyridoxine). Homocystinuria should be suspected in stroke patients of young age, especially if thy have nontraumatic lens dislocation or marfanoid features. We report a patient with homocystinuria complicated by cerebral venous sinus thrombosis which was aggrevated after cerebral angiography.
Adolescent
;
Angiography
;
Biopsy
;
Brain
;
Carotid Artery, Internal
;
Cerebral Angiography
;
Congenital Abnormalities
;
Constriction, Pathologic
;
Female
;
Homocystine
;
Homocystinuria*
;
Humans
;
Intellectual Disability
;
Lens Subluxation
;
Magnetic Resonance Imaging
;
Metabolism
;
Methionine
;
Phlebography
;
Plasma
;
Quadriplegia
;
Rabeprazole
;
Scoliosis
;
Seizures
;
Sinus Thrombosis, Intracranial
;
Stroke
;
Stupor
;
Superior Sagittal Sinus*
;
Thrombosis*
;
Vascular Diseases
;
Vitamins
3.Categorization of Regional Delivery System for the Elderly Chronic Health Care and Long-Term Care
Nan-He YOON ; Sunghun YUN ; Dongmin SEO ; Yoon KIM ; Hongsoo KIM
Health Policy and Management 2023;33(4):479-488
Background:
By applying the suggested criteria for needs-based chronic medical care and long-term care delivery system for the elderly, the current status of delivery system was identified and regional delivery systems were categorized according to quantity and quality of delivery system.
Methods:
National claims data were used for this study. All claims data of medical and long-term care uses by the elderly and all claims data from long-term care hospitals and nursing homes in 2016 were analyzed to categorize the regional medical and long-term care delivery system. The current status of the delivery system with a high possibility of transition to a needs-based appropriate delivery system was identified. The necessary and actual amount of regional supply was calculated based on their needs, and the structure of delivery systems was evaluated in terms of the needs-based quality of the system. Finally, all regions were categorized into 15 types of medical and care delivery systems for the elderly.
Results:
Of the total 55 regions, 89.1% of regions had an oversupply of elderly medical and care services compared to the necessary supply based on their needs. However, 69.1% of regions met the criteria for less than two types of needs groups, and 21.8% of regions were identified as regions where the numbers of institutions or regions with a high possibility of transition to an appropriate delivery system were below the average levels for all four needs groups.
Conclusion
In order to establish an appropriate community-based integrated elderly care system, it is necessary to analyze the characteristics of the regional delivery system categories and to plan a needs-based delivery system regionally.
4.New-Onset Neuromyelitis Optica Spectrum Disorder during Pregnancy: A Case Report
So Hee LEE ; Seongheon KIM ; Se Jin LEE ; Sung Hun KIM ; Sunghun NA
Perinatology 2025;36(1):32-36
Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory disease that most often affects the optic nerves and spinal cord. We describe a case of 36-year-old woman presented at 13 weeks of gestation with 4 extremities paresthesia and weakness that had lasted for two months at her first visit to our hospital. She had two previous uncomplicated full-term vaginal deliveries and no significant medical or family history. Spine magnetic resonance imaging (MRI) showed extensive cervical cord lesion and aquaporin-4 antibodies were strongly positive, confirming the diagnosis of NMOSD. Initial management with high-dose corticosteroids and plasmapheresis was done and she showed substantial improvement, but she revisited hospital at 26 weeks of gestational age due to visual disturbance and aggravated weakness. Relapse of NMOSD was confirmed by spine MRI, so rituximab therapy was initiated at 28 weeks of gestational age for prevention of recurrence.The patient showed clinical improvement with no adverse effects and relapse of symptoms. She successfully delivered a healthy male infant at 39 weeks and 3 days of gestational age through uncomplicated vaginal delivery. This case demonstrates successful management of new-onset NMOSD during pregnancy using a multi-modal treatment approach including rituximab.
5.New-Onset Neuromyelitis Optica Spectrum Disorder during Pregnancy: A Case Report
So Hee LEE ; Seongheon KIM ; Se Jin LEE ; Sung Hun KIM ; Sunghun NA
Perinatology 2025;36(1):32-36
Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory disease that most often affects the optic nerves and spinal cord. We describe a case of 36-year-old woman presented at 13 weeks of gestation with 4 extremities paresthesia and weakness that had lasted for two months at her first visit to our hospital. She had two previous uncomplicated full-term vaginal deliveries and no significant medical or family history. Spine magnetic resonance imaging (MRI) showed extensive cervical cord lesion and aquaporin-4 antibodies were strongly positive, confirming the diagnosis of NMOSD. Initial management with high-dose corticosteroids and plasmapheresis was done and she showed substantial improvement, but she revisited hospital at 26 weeks of gestational age due to visual disturbance and aggravated weakness. Relapse of NMOSD was confirmed by spine MRI, so rituximab therapy was initiated at 28 weeks of gestational age for prevention of recurrence.The patient showed clinical improvement with no adverse effects and relapse of symptoms. She successfully delivered a healthy male infant at 39 weeks and 3 days of gestational age through uncomplicated vaginal delivery. This case demonstrates successful management of new-onset NMOSD during pregnancy using a multi-modal treatment approach including rituximab.
6.New-Onset Neuromyelitis Optica Spectrum Disorder during Pregnancy: A Case Report
So Hee LEE ; Seongheon KIM ; Se Jin LEE ; Sung Hun KIM ; Sunghun NA
Perinatology 2025;36(1):32-36
Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory disease that most often affects the optic nerves and spinal cord. We describe a case of 36-year-old woman presented at 13 weeks of gestation with 4 extremities paresthesia and weakness that had lasted for two months at her first visit to our hospital. She had two previous uncomplicated full-term vaginal deliveries and no significant medical or family history. Spine magnetic resonance imaging (MRI) showed extensive cervical cord lesion and aquaporin-4 antibodies were strongly positive, confirming the diagnosis of NMOSD. Initial management with high-dose corticosteroids and plasmapheresis was done and she showed substantial improvement, but she revisited hospital at 26 weeks of gestational age due to visual disturbance and aggravated weakness. Relapse of NMOSD was confirmed by spine MRI, so rituximab therapy was initiated at 28 weeks of gestational age for prevention of recurrence.The patient showed clinical improvement with no adverse effects and relapse of symptoms. She successfully delivered a healthy male infant at 39 weeks and 3 days of gestational age through uncomplicated vaginal delivery. This case demonstrates successful management of new-onset NMOSD during pregnancy using a multi-modal treatment approach including rituximab.
7.New-Onset Neuromyelitis Optica Spectrum Disorder during Pregnancy: A Case Report
So Hee LEE ; Seongheon KIM ; Se Jin LEE ; Sung Hun KIM ; Sunghun NA
Perinatology 2025;36(1):32-36
Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory disease that most often affects the optic nerves and spinal cord. We describe a case of 36-year-old woman presented at 13 weeks of gestation with 4 extremities paresthesia and weakness that had lasted for two months at her first visit to our hospital. She had two previous uncomplicated full-term vaginal deliveries and no significant medical or family history. Spine magnetic resonance imaging (MRI) showed extensive cervical cord lesion and aquaporin-4 antibodies were strongly positive, confirming the diagnosis of NMOSD. Initial management with high-dose corticosteroids and plasmapheresis was done and she showed substantial improvement, but she revisited hospital at 26 weeks of gestational age due to visual disturbance and aggravated weakness. Relapse of NMOSD was confirmed by spine MRI, so rituximab therapy was initiated at 28 weeks of gestational age for prevention of recurrence.The patient showed clinical improvement with no adverse effects and relapse of symptoms. She successfully delivered a healthy male infant at 39 weeks and 3 days of gestational age through uncomplicated vaginal delivery. This case demonstrates successful management of new-onset NMOSD during pregnancy using a multi-modal treatment approach including rituximab.
8.New-Onset Neuromyelitis Optica Spectrum Disorder during Pregnancy: A Case Report
So Hee LEE ; Seongheon KIM ; Se Jin LEE ; Sung Hun KIM ; Sunghun NA
Perinatology 2025;36(1):32-36
Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory disease that most often affects the optic nerves and spinal cord. We describe a case of 36-year-old woman presented at 13 weeks of gestation with 4 extremities paresthesia and weakness that had lasted for two months at her first visit to our hospital. She had two previous uncomplicated full-term vaginal deliveries and no significant medical or family history. Spine magnetic resonance imaging (MRI) showed extensive cervical cord lesion and aquaporin-4 antibodies were strongly positive, confirming the diagnosis of NMOSD. Initial management with high-dose corticosteroids and plasmapheresis was done and she showed substantial improvement, but she revisited hospital at 26 weeks of gestational age due to visual disturbance and aggravated weakness. Relapse of NMOSD was confirmed by spine MRI, so rituximab therapy was initiated at 28 weeks of gestational age for prevention of recurrence.The patient showed clinical improvement with no adverse effects and relapse of symptoms. She successfully delivered a healthy male infant at 39 weeks and 3 days of gestational age through uncomplicated vaginal delivery. This case demonstrates successful management of new-onset NMOSD during pregnancy using a multi-modal treatment approach including rituximab.
9.Phytochemical Identification from Boehmeria nivea Leaves and Analysis of (-)-Loliolide by HPLC.
Sunghun CHO ; Dong Gu LEE ; Yong Su JUNG ; Ho Bang KIM ; Eun Ju CHO ; Sanghyun LEE
Natural Product Sciences 2016;22(2):134-139
Phytochemicals were isolated from leaves of the fiber crop, ramie (Boehmeria nivea, Bn), using open column chromatography and medium pressure liquid chromatography. Their structures were identified as β-sitosterol, (-)-loliolide, rutin, and pyrimidinedione by MS, ¹H-, and ¹³C-NMR spectroscopic analysis. Among them, (-)-loliolide was isolated for the first time from B. nivea. A content analysis of (-)-loliolide in B. nivea collected from different regions and harvest times was conducted by HPLC. The highest content of (-)-loliolide was found in Bn-23 harvested in September. These results will be helpful to use the plant which harvest in September as a high content phytochemical additive in food, health supplements, and medicinal products.
Boehmeria*
;
Chromatography
;
Chromatography, High Pressure Liquid*
;
Chromatography, Liquid
;
Phytochemicals
;
Plants
;
Rutin
;
Urticaceae
10.Familial Hemiplegic Migraine with Prolonged Coma and Cerebellar Atrophy: CACNA1A T666M Mutation in a Korean Family.
Kyung Ho CHOI ; Jang Su KIM ; Seo Young LEE ; Suk Won RYU ; Sam Su KIM ; Seung Hwan LEE ; Sunghun KIM ; Hee Kwon PARK
Journal of Korean Medical Science 2012;27(9):1124-1127
We report the first Korean patient with familial hemiplegic migraine type 1, with clinical and multimodal imaging findings. A 43-yr-old man was admitted for right hemianopia and aphasia, followed by coma. MRI showed only cerebellar atrophy. CT angiography showed mild vasodilation of intracranial blood vessels and increased vascularity in the left hemisphere and perfusion-weighted imaging showed elevated cerebral blood flow. Gene analysis of the patient and his mother led to the identification of a heterozygous point mutation (1997C-->T, T666M) in exon 16 of the CACNA1A gene. Familial hemiplegic migraine should be considered in patients with episodic neurological dysfunction with cerebellar atrophy.
Asian Continental Ancestry Group/*genetics
;
Atrophy/genetics/metabolism
;
Calcium Channels/*genetics
;
Cerebellum/blood supply/*pathology
;
Cerebral Angiography
;
Coma/*diagnosis
;
Exons
;
Heterozygote
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Migraine with Aura/*diagnosis/genetics
;
Point Mutation
;
Republic of Korea
;
Tomography, X-Ray Computed